Corrigendum: Targeting HER3 to overcome RGFR TKI resistance in NSCLC

• Qiuqiang Chen,
• Gang Jia,
• Xilin Zhang,
• Wenxue Ma

Affiliations

Qiuqiang Chen

Key Laboratory for Translational Medicine, The First Affiliated Hospital, Huzhou University, Huzhou, Zhejiang, China

Gang Jia

Department of Medical Oncology, Henan Provincial People’s Hospital, People’s Hospital of Zhengzhou University, Zhengzhou, Henan, China

Xilin Zhang

Key Laboratory for Translational Medicine, The First Affiliated Hospital, Huzhou University, Huzhou, Zhejiang, China

Wenxue Ma

Department of Medicine, Moores Cancer Center, and Sanford Stem Cell Institute, University of California San Diego, La Jolla, CA, United States